Jeffrey M Isner is a notable inventor based in Boston, MA, who has made significant contributions to the field of cardiac treatment. With a total of four patents to his name, Isner has focused on developing innovative techniques that enhance the treatment of heart conditions.

Latest Patents

Isner's latest patents include a catheter technique for the percutaneous treatment of idiopathic hypertrophic subaortic stenosis (IHSS) and hypertrophic cardiomyopathy (HCM). These conditions involve the thickening of the septum in the left ventricle, which can lead to reduced ventricular performance. His invention utilizes laser energy delivered through fiber optics to irradiate the thickened septum, thereby reducing tissue volume and improving left ventricular function. Another significant patent involves a catheter technique for treating ventricular tachycardia. This method includes endocardial mapping to locate tachycardial foci and other conduction abnormalities. A special catheter with an optical fiber is inserted into a blood vessel and advanced into the ventricle, where a medical laser is used to photocoagulate or ablate the tissue at each tachycardia-generating site.

Career Highlights

Throughout his career, Isner has worked with various companies, including Angelase, Inc. and Angeion Corporation. His work has been instrumental in advancing medical technologies that address critical heart conditions.

Collaborations

Isner has collaborated with professionals in the field, including Richard Clarke, to further enhance the development of his innovative techniques.

Conclusion

Jeffrey M Isner's contributions to cardiac treatment through his patents demonstrate his commitment to improving patient outcomes in heart health. His innovative approaches continue to pave the way for advancements in medical technology.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com